Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Genetic risk factors for Polycystic Ovary Syndrome can affect men too, not just women.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Men can have genetic risks for PCOS-related traits like obesity and diabetes.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

DHT may increase the risk of heart disease and death in elderly men.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Anabolic steroid users may face higher risk of severe COVID-19.

Medications for PCOS don't seem to raise heart disease risk.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

People with vitiligo may have a lower risk of heart disease.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Obesity is linked to higher metabolic syndrome and LH/FSH ratios, but no significant differences exist among PCOS phenotypes.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

High levels of androgens during early development may cause PCOS-like symptoms.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.